LIG Audit Status
This page is public. The editing interface lives at /cgi-bin/audit.cgi and requires login. Full-text AI processing status is at /cgi-bin/fulltext-status.cgi; paper upload is at /cgi-bin/fulltext-upload.cgi.
Batch audit-20260421-labels-seed42 · created 2026-04-21 07:03 · seed 42
caucasian
25 reviewed / 25 total
0 pending
Confirmed caucasian 25 · Not caucasian on review 0
white
25 reviewed / 25 total
0 pending
Confirmed white 24 · Not white on review 1
european
10 reviewed / 25 total
15 pending
Confirmed european 10 · Not european on review 0
other
25 reviewed / 25 total
0 pending
Confirmed other 25 · Not other on review 0
none of these labels
0 reviewed / 100 total
100 pending
Confirmed none of these labels 0 · Uses tracked labels on review 0
["Candidate gene analysis in human neural tube defects"]
American Journal of Medical Genetics Part C: Seminars in Medical Genetics · 2005 · article 154355026 · 10.1002/ajmg.c.30048
Review target: other. Review status: reviewed
Audit result: confirmed other · reviewer georgina · 2026-05-26 21:46
Classifier flags: other: Irish population
<jats:title>Abstract</jats:title><jats:p>Biochemical and developmental pathways, mouse models, and positional evidence have provided numerous candidate genes for the study of human neural tube defects. In a survey of 80 studies on 38 candidate genes, few found significant results in human populations through case‐control or family‐based association studies. While the folate pathway has been explored extensively, only the<jats:italic>MTHFR</jats:italic>677C > T polymorphism was significant, and only in an Irish population. Developmental pathways such as the Wnt signaling pathway and<jats:italic>Hox</jats:italic>genes have also been explored without positive results. More than 90 mouse candidates have been identified through spontaneous and knockout mutations, but only the T locus (mouse<jats:italic>Brachyury</jats:italic>gene) showed association in an initial study that was not confirmed on follow‐up. Positional candidates have been derived from cytogenetic evidence, but preliminary genomic screens have limited power due to small sample sizes. Future studies would increase their power to detect association by using more samples. In addition a clarification of the phenotype would be beneficial as many studies used different inclusion criteria. Incorporating several types of data could highlight better candidates, as would looking beyond the traditional sources for candidate genes. Recent studies of an energy metabolism gene (<jats:italic>UCP2</jats:italic>) and vitamin B metabolism (Transcoalbumin) have produced promising results. Utilizing other model organisms may also be beneficial, as in a recent study from a chick model of NTDs in NCAM1. New approaches combined with traditional methods and increased sample sizes will help prioritize human NTD candidate genes and clarify the complex etiology of this condition. © 2005 Wiley‐Liss, Inc.</jats:p>